Casein Phosphopeptide--amorphous Calcium Phosphate on Human Enamel Subjected to in Vivo Acid Attacks
Launched by FUJIAN MEDICAL UNIVERSITY · Feb 6, 2018
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 to 60 years of age and in good general health
- • Dental erosion and wear degree is 0-1
- Exclusion Criteria:
- • Systemic diseases or oral mucosal disorders
- • Current orthodontic treatment
- • Pregnancy
- • Known allergies to the experimental drink
- • Had been given drugs which lead to dry oral more regularly within half a year
About Fujian Medical University
Fujian Medical University is a prestigious academic institution located in Fujian Province, China, dedicated to advancing medical education, research, and clinical practice. With a strong emphasis on innovative healthcare solutions, the university actively engages in clinical trials to explore new therapeutic interventions and improve patient outcomes. Its comprehensive research programs are supported by a team of experienced professionals and state-of-the-art facilities, enabling the university to contribute significantly to the global medical community. Through its commitment to excellence and collaboration, Fujian Medical University aims to enhance the quality of healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Hao Yu, DDS, PhD
Principal Investigator
School and Hospital of Stomatology, Fujian Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials